Inventor · disambiguated record
Servando Palencia
Also filed as: PALENCIA SERVANDO
3 granted patents·5 pending applications·0 citations·filing 2001–2025
48Inventor score
Files withFIVE PRIME THERAPEUTICS INC5
Top patents by PatentIndex Score
8 records- 0169US2023052212A1Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0265US2025223367A1Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0356US11447553B2FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Sep 20, 2022·0 cites·10 claims
- 0453US10537611B2Methods of treating lung cancerFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·0 cites·20 claims
- 0550US10016484B2Methods of treating lung cancerFIVE PRIME THERAPEUTICS INC·Filed 2012·Granted Jul 10, 2018·0 cites·20 claims
- 0643US2004106116A1Methods and materials relating to hematopoietic cytokine-like polypeptides and polynucleotidesFiled 2001·Application pending·0 cites
- 0737US2003144491A1Methods and materials relating to cadherin-like polypeptides and polynucleotidesFiled 2001·Application pending·0 cites
- 0835US2004132022A1Methods and materials relating to soluble transforming growth factor alpha-like polypeptides and polynucleotidesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Servando Palencia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →